A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 31,797 shares of VRTX stock, worth $13 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
31,797
Previous 29,457 7.94%
Holding current value
$13 Million
Previous $13.8 Million 7.11%
% of portfolio
0.24%
Previous 0.26%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$460.0 - $505.78 $1.08 Million - $1.18 Million
2,340 Added 7.94%
31,797 $14.8 Million
Q2 2024

Aug 12, 2024

BUY
$392.81 - $485.53 $1.76 Million - $2.17 Million
4,470 Added 17.89%
29,457 $13.8 Million
Q1 2024

May 09, 2024

BUY
$407.69 - $446.08 $370,590 - $405,486
909 Added 3.78%
24,987 $10.4 Million
Q4 2023

Feb 07, 2024

SELL
$343.0 - $410.68 $575,211 - $688,710
-1,677 Reduced 6.51%
24,078 $9.8 Million
Q3 2023

Nov 08, 2023

BUY
$338.18 - $362.46 $505,579 - $541,877
1,495 Added 6.16%
25,755 $8.96 Million
Q2 2023

Jul 28, 2023

BUY
$314.42 - $351.91 $592,367 - $662,998
1,884 Added 8.42%
24,260 $8.54 Million
Q1 2023

May 10, 2023

BUY
$283.23 - $323.1 $476,109 - $543,131
1,681 Added 8.12%
22,376 $7.05 Million
Q4 2022

Feb 10, 2023

BUY
$285.76 - $321.48 $151,738 - $170,705
531 Added 2.63%
20,695 $5.98 Million
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $397,053 - $443,018
1,450 Added 7.75%
20,164 $5.84 Million
Q2 2022

Aug 09, 2022

BUY
$234.96 - $292.55 $1.13 Million - $1.41 Million
4,809 Added 34.58%
18,714 $5.27 Million
Q1 2022

May 16, 2022

BUY
$221.42 - $260.97 $755,042 - $889,907
3,410 Added 32.49%
13,905 $3.63 Million
Q4 2021

Feb 23, 2022

BUY
$177.01 - $223.45 $1.02 Million - $1.28 Million
5,739 Added 120.67%
10,495 $2.31 Million
Q3 2021

Nov 09, 2021

BUY
$181.39 - $202.99 $405,406 - $453,682
2,235 Added 88.66%
4,756 $863,000
Q2 2021

Aug 11, 2021

SELL
$187.49 - $221.1 $327,920 - $386,703
-1,749 Reduced 40.96%
2,521 $508,000
Q1 2021

Apr 28, 2021

BUY
$207.02 - $241.31 $251,736 - $293,432
1,216 Added 39.82%
4,270 $918,000
Q4 2020

Jan 20, 2021

BUY
$207.01 - $276.09 $632,208 - $843,178
3,054 New
3,054 $722,000
Q4 2020

Jan 19, 2021

SELL
$207.01 - $276.09 $642,559 - $856,983
-3,104 Closed
0 $0
Q3 2020

Oct 26, 2020

BUY
$255.65 - $303.1 $362,000 - $429,189
1,416 Added 83.89%
3,104 $845,000
Q2 2020

Jul 27, 2020

BUY
$225.48 - $295.8 $106,201 - $139,321
471 Added 38.7%
1,688 $490,000
Q1 2020

May 13, 2020

BUY
$199.77 - $247.81 $243,120 - $301,584
1,217 New
1,217 $290,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.